DCRI Faculty highlights from ESC-HF
Three faculty cardiologists from the Duke Clinical Research Institute presented late-breaking research results and shared their insights via panel discussions and moderated posters as part of the E
Early Dexamethasone Administration Can Reduce Death or Discharge to Hospice Among Certain Types Of COVID-19 Patients, DCRI Study Shows
Results from a Duke Clinical Research Institute study that were recently published in JAMA Network Open expand the depth of understanding of how dexamethasone can improve outcomes among patients ho
Why Clinical Research Matters: A 14-year-old’s Perspective on Her Experience in the GenARA Trial
Patients and their families play one of the most important roles in clinical research.
STAT News First Opinion: DCRI’s Perakslis Pens Op-ed on Proposed Health Data Rulemaking
Duke Clinical Research Institute Chief Digital and Science Officer Eric Perakslis, PhD, co-authored an opinion piece with Katie D. McMillan and Jessilyn Dunn published in STAT News today, reflecting on proposed rulemaking that is intended to protect health data in an era of rapidly changing legislation surrounding abortion.
Three DCRI Faculty Receive Distinguished Professorships
The Duke Clinical Research Institute celebrates three of its faculty members who were recently awarded distinguished professorships.
Research Study on Comfort of the New FLUME Catheter to Begin Recruitment
The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced the launch of a study to gather real-world data on patient experiences with the new FLUME catheter.
Duke-led consortium envisions new plan for organ transplant management
While organ transplantation is one of the true modern miracles of healthcare, oversight of the U.S. national system regulating and governing solid organ transplantation has been criticized on multiple levels. Ultimately, an overhaul is needed to grow the number of organ transplants, reduce waste, eliminate inequities, and usher in a state-of-the-art information system.
Sixth Pharmaceutical Company Joins the CardioHealth Alliance, Further Expanding Reach and Impact of Evidence-Based Prevention and Care
CardioHealth Alliance welcomed Novo Nordisk Inc. to the CardioHealth Alliance group on March 9, 2023, aiming to expedite evidence-based solutions for prevention and care of cardiovascular, renal and metabolic cardio-metabolic diseases.
DCRI HEAL Connections Team Assembles Naloxone Kits at Team Building Event
The HEAL Connections team – led by DCRI faculty Asheley Skinner, PhD (Population Health) and Rachel Greenberg, MD, MB, MHS, and Christoph Hornik, MD, PhD, MPH (Pediatrics) – partnered with the North Carolina Harm Reduction Coalition (NCHRC) to make naloxone kits on March 21 as an opportunity to connect in-person and learn more about community efforts to stop overdose deaths.
DCRI Releases 2022 Impact Report
At the DCRI, we’re bringing creative solutions to the world’s most vexing health problems.